Insightful webinars for smart catheter clearance with urokinase

Insightful webinars for smart catheter clearance with urokinase

Stay informed with the latest insights into catheter management, thrombolytic treatments and best practices for using Syner-KINASE® by joining our expert-led webinars. These are designed to provide healthcare professionals with valuable knowledge to help ensure catheter patency, high quality patient care and streamlined clinical workflows.

Upcoming webinars

Upcoming webinars

Central venous catheters: complications, causes and care

Date: Monday the 18th of August 2025, 17.00 BST

Speaker: Gema Munoz-Mozas, Lead Vascular Access Nurse at the Royal Marsden NHS Foundation Trust

Join Lead Vascular Access Nurse, Gema Munoz-Mozas, for a clinical review of the most frequent complications in central venous access, and how to prevent and resolve them. This educational, CPD-accredited event – organised by Syner-Med – will cover common causes of catheter occlusion, infection and malfunction, with practical strategies for line preservation and troubleshooting across oncology, haematology and critical care settings. The webinar is part of a promotional series for Syner-KINASE® (urokinase).

Unable to attend the live session? Register in advance to receive a full recording.

Unlocking Flow: Real-World Success of Syner-Kinase®(urokinase) in Restoring Dialysis Catheter Patency

Date: Tuesday the 16th of September 2025, 17.00 BST

Speaker: Dr Mick Kumwenda, Consultant Nephrologist at Glan Clwyd Hospital, Wales

Join us for a practical, case-based webinar exploring how Syner-Kinase® (urokinase) is used in real-world dialysis settings to effectively manage catheter occlusions. Based on insights from the Passport 1 programme, this session highlights clinical experiences, decision pathways, and outcomes in restoring patency and avoiding catheter replacement. Even if you can’t make the date, please register, and we will send you a recording of the webinar. This is a Syner-Med organised educational event. This CPD-accredited session will highlight thrombotic catheter occlusion clearance rates, patient outcomes, and key learnings for nephrology and vascular access teams seeking practical solutions backed by NHS evidence. This event is part of a promotional series for Syner-Kinase®.

Unable to attend the live session? Register in advance to receive a full recording.

Optimising use of Syner-Kinase® (urokinase) in Non-Renal (Oncology) Catheters and CVCs

Date: Wednesday the 22nd of October 2025, 17.00 BST.

Speaker: Dr Mick Kumwenda, Consultant Nephrologist at Glan Clwyd Hospital, Wales

This focused session explores the application of Syner-Kinase® (urokinase) in oncology and other non-renal settings, where catheter-related occlusion presents unique challenges. Drawing on real-world experiences from the Passport 2 programme, the webinar provides practical guidance on dosing, administration, and patient selection to support central venous catheter (CVC) function and continuity of care. This is a Syner-Med organised educational event. Learn how to apply structured approaches to dosing and administration, optimise lock and infusion protocols—all based on insights from routine NHS practice. This event is part of a promotional series for Syner-Kinase® (urokinase).

Unable to attend the live session? Register in advance to receive a full recording.

Discover more about Syner-KINASE

Discover more about Syner-KINASE

Medical stent partially blocked by arterial plaque buildup with fibrous tissue, visualized in a 3D rendering to illustrate cardiovascular disease and artery obstruction.

Learn about catheter thrombosis and why thrombolytic therapy is essential

Syner-Kinase® Human Urokinase vials and packaging in 10,000, 25,000, and 100,000 IU doses

Find out more about
Syner-KINASE®

Audience attending a medical conference, with expert speakers on stage discussing innovations in thrombolytic therapy and cardiovascular care.

Watch expert-led discussions on thrombolysis for catheter blockages

Have questions or need more information?

Have questions or need more information?

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. 

Adverse events should also be reported to Syner-Med (PP) Ltd. Tel: +44 (0)208 655 6380

For Syner-KINASE prescribing information, click here